Use of topical calcipotriol for identification of patients with psoriasis in administrative healthcare data – a validation study

Use of topical calcipotriol for identification of patients with psoriasis in administrative healthcare data – a validation study:

Abstract

Calcipotriol has been used to treat psoriasis for more than three decades. Previous interview data of 44 Danish dermatologists and 93 general practitioners have indicated that calcipotriol (alone or combined with topical corticosteroids [TCS]) was the most commonly used treatment for newly diagnosed psoriasis patients (48‐54%) and that this was used in 71% of patients receiving continuing topical treatment. In settings where complete data from general practitioners and private practice dermatologists are lacking, calcipotriol is frequently used as a proxy for identification of patients with psoriasis.